Alicia M Maurer-vallier, MA, LAMFT | |
200 S Main St, Attleboro, MA 02703-4006 | |
(508) 226-6031 | |
Not Available |
Full Name | Alicia M Maurer-vallier |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 200 S Main St, Attleboro, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417231754 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | LAMFT-10312 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alicia M Maurer-vallier, MA, LAMFT 200 S Main St, Attleboro, MA 02703-4006 Ph: () - | Alicia M Maurer-vallier, MA, LAMFT 200 S Main St, Attleboro, MA 02703-4006 Ph: (508) 226-6031 |
News Archive
Researchers at Columbia University's Mailman School of Public Health analyzed the results of the Oregon Health Experiment, where eligible uninsured individuals were randomly assigned Medicaid or to stay with their current care. Considered controversial because the experiment found no measurable gains for physical health it did reveal benefits for mental health, financial wellbeing, and preventive screening.
Published today in Nature, the findings detail a new gene locus that can explain why, in communities where everyone is constantly exposed to malaria, some children develop severe malaria and others don't. Now, researchers can be sure that this particular stretch of our DNA plays a crucial role in the progression of the disease.
ATLAB Pharma SAS and BZL Biologics LLC have entered into a sublicense agreement to develop 177Lu-J591 for cancer treatment. It includes exclusive rights to manufacture, develop and commercialize this radiopharmaceutical product worldwide as well as a joint Phase IIB/III clinical validation program.
Team members from Ulster Rugby have been working with researchers in the School of Psychology at Queen's on a range of virtual training scenarios that test expert players' perceptual skills.
BioMarin Pharmaceutical Inc. today announced the initiation of a Phase 1 trial for BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, for the treatment of patients with advanced hematological malignancies.
› Verified 8 days ago
Sage Goodwin, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 67 Mechanic St, Attleboro, MA 02703 Phone: 508-223-4691 |